Dwi U Kemaladewi Selected Research

Antisense Oligonucleotides

1/2014	Novel Ex Vivo Culture Method for the Study of Dupuytren's Disease: Effects of TGFβ Type 1 Receptor Modulation by Antisense Oligonucleotides.
1/2013	Antisense-oligonucleotide mediated exon skipping in activin-receptor-like kinase 2: inhibiting the receptor that is overactive in fibrodysplasia ossificans progressiva.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Dwi U Kemaladewi Research Topics

Disease

4	Duchenne Muscular Dystrophy (Muscular Dystrophy, Becker) 03/2016 - 04/2011
1	Paralysis (Palsy) 01/2019
1	Rare Diseases (Rare Disease) 01/2019
1	Fibrosis (Cirrhosis) 04/2014
1	Dupuytren Contracture (Dupuytrens Contracture) 01/2014
1	Myositis Ossificans (Fibrodysplasia Ossificans Progressiva) 01/2013

Drug/Important Bio-Agent (IBA)

3	DystrophinIBA 03/2016 - 04/2011
2	Antisense OligonucleotidesIBA 01/2014 - 01/2013
1	RNA (Ribonucleic Acid)IBA 01/2019
1	Proteins (Proteins, Gene)FDA Link 01/2019
1	UtrophinIBA 01/2016
1	Transforming Growth Factors (Transforming Growth Factor)IBA 04/2014
1	Activin Receptors (Activin Receptor)IBA 01/2013
1	MyostatinIBA 04/2011

Therapy/Procedure

1	Intramuscular Injections 04/2014